Precigen, Inc. (PGEN)
6.19
-0.20
(-3.13%)
USD |
NASDAQ |
Oct 23, 16:00
6.185
0.00 (0.00%)
After-Hours: 20:00
Precigen Price to Book Value : 50.85 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 50.85 |
| October 22, 2026 | 52.50 |
| October 21, 2026 | 54.22 |
| October 20, 2026 | 56.11 |
| October 19, 2026 | 54.72 |
| October 16, 2026 | 52.46 |
| October 15, 2026 | 59.11 |
| October 14, 2026 | 60.43 |
| October 13, 2026 | 61.45 |
| October 12, 2026 | 62.93 |
| October 09, 2026 | 64.16 |
| October 08, 2026 | 62.44 |
| October 07, 2026 | 61.95 |
| October 06, 2026 | 62.03 |
| October 05, 2026 | 63.59 |
| October 02, 2026 | 70.16 |
| October 01, 2026 | 67.45 |
| September 30, 2026 | 70.33 |
| September 29, 2026 | 66.14 |
| September 28, 2026 | 64.16 |
| September 25, 2026 | 63.67 |
| September 24, 2026 | 63.26 |
| September 23, 2026 | 61.12 |
| September 22, 2026 | 64.82 |
| September 21, 2026 | 63.26 |
| Date | Value |
|---|---|
| September 18, 2026 | 63.92 |
| September 17, 2026 | 64.66 |
| September 16, 2026 | 61.08 |
| September 15, 2026 | 57.51 |
| September 14, 2026 | 56.28 |
| September 11, 2026 | 56.28 |
| September 10, 2026 | 54.88 |
| September 09, 2026 | 55.87 |
| September 08, 2026 | 56.44 |
| September 04, 2026 | 58.33 |
| September 03, 2026 | 58.66 |
| September 02, 2026 | 57.59 |
| September 01, 2026 | 56.36 |
| August 31, 2026 | 56.93 |
| August 28, 2026 | 57.10 |
| August 27, 2026 | 59.07 |
| August 26, 2026 | 60.96 |
| August 25, 2026 | 59.81 |
| August 24, 2026 | 58.91 |
| August 21, 2026 | 59.15 |
| August 20, 2026 | 61.12 |
| August 19, 2026 | 58.82 |
| August 18, 2026 | 55.46 |
| August 17, 2026 | 53.81 |
| August 14, 2026 | 50.12 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Anika Therapeutics, Inc. | 2.088 |
| Aldeyra Therapeutics, Inc. | 1.034 |
| Repligen Corp. | 4.727 |
| AC Immune SA | 5.057 |
| Amgen, Inc. | 20.32 |
Price to Book Value Related Metrics
| PS Ratio | 25.80 |
| PEG Ratio | -0.036 |
| Price | 6.19 |
| Earnings Yield | -17.76% |
| Market Cap | 2.216B |
| PEGY Ratio | -0.036 |